US Patent Issued to TELIGENE US on June 24 for "Substituted macrocycles useful as kinase inhibitors" (California Inventor)

ALEXANDRIA, Va., June 25 -- United States Patent no. 12,338,251, issued on June 24, was assigned to TELIGENE US LLC (Thousand Oaks, Calif.).

"Substituted macrocycles useful as kinase inhibitors" was invented by Dawei Zhang (Thousand Oaks, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are novel substituted macrocycle compounds according to Formula I, or pharmaceutically acceptable salts, solvates, or enantiomers thereof. The compounds and compositions of the present invention have protein kinases inhibitory activities and are expected to be useful for the treatment of protein kinases mediated diseases and conditions."

The patent was filed on Jan. 17, 2022, under Application No. 17/57...